State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...
The NHS plans to roll out Mounjaro, a weight-loss jab that can help users lose up to a quarter of their body weight, making it more potent than Ozempic. Anna Magee explains how to choose the best opti ...
Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...
A QUARTER of a million more Brits will be put on NHS fat jabs in the next three years under plans to crush England’s obesity crisis. Super-strong tirzepatide, which can help slimmers lose a ...
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...
Liraglutide lowered body mass, slowed weight gain and improved health markers ... in adults and children ages 10 and older and as Saxenda to treat obesity in adults and children ages 12 to 17.
Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11, according to ...
13 in the journal JAMA Network Open. By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.